Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial
Bonthapally, V Ma, E Viviani, S Radford, John A Brice, P von Tresckow, B Thomas, E Teasell, J Gnanasakthy, A Odom, D
Bonthapally, V
Ma, E
Viviani, S
Radford, John A
Brice, P
von Tresckow, B
Thomas, E
Teasell, J
Gnanasakthy, A
Odom, D
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial. 2015, 100 579-580 Haematologica